Table 2 Core details of the references mentioned in the analysis of BMD and RF in Table 1
From: Review article: effects of type 2 diabetes therapies on bone metabolism
References | Study category | Time of therapy before analysis (months) mean or range | HbA1c of the population at the baseline (%) Mean or range | Age (years) mean or range | Gender (M/F) |
|---|---|---|---|---|---|
[21] | RCT | 48 | 7.4 | 56 | M/F |
[22] | RCT | 12 | 7.4 | 57 | M/F |
[26] | LC | 48 | 8.4 | 73 | M/F |
[39] | LC | NA | NA | 62 | M/F |
[40] | RCT | 12 | 7.3 | 63 | F |
[58] | MA | 3–48 | 6.7–9.9 | 50–75 | M/F |
[67] | RCT | 12 | 6.0 | 57 | M/F |
[68] | MA | 6–24 | 6.7–9.9 | 50–72 | M/F |
[69] | LC | 12 | 8.3 | 59 | M/F |
[72] | RCT | 29 | 8.2 | 62 | M/F |
[73] | RCT | 43 | 8.2 | 63 | M/F |
[77] | RCT | 24 | 6.5–8.5 | 61 | M/F |
[78] | RCT | 11 | 7.2 | 61 | M/F |
[79] | RCT | 24 | 7.7 | 64 | M/F |
[83] | MA | 6–37 | NA | NA | M/F |
[89] | LC | 114 | NA | 61 | F |
[90] | RCT | 18 | 8.6 | 51 | M/F |
[91] | CC | 49 | 8.0 | 70 | M/F |